We serve Chemical Name:N’-[(4-methoxyphenyl)methyl]-N,N-dimethyl-N’-(1,3-thiazol-2-yl)ethane-1,2-diamine CAS:553-13-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
![N'-[(4-methoxyphenyl)methyl]-N,N-dimethyl-N'-(1,3-thiazol-2-yl)ethane-1,2-diamine](https://a.dearchem.com/CAS2/553-13-9.png)
Chemical Name:N’-[(4-methoxyphenyl)methyl]-N,N-dimethyl-N’-(1,3-thiazol-2-yl)ethane-1,2-diamine
CAS.NO:553-13-9
Synonyms:N-(4-Methoxy-benzyl)-N’,N’-dimethyl-N-thiazol-2-yl-aethylendiamin;N-(4-methoxy-benzyl)-N’,N’-dimethyl-N-thiazol-2-yl-ethane-1,2-diamine;ZOLAMINE;Zolamine [INN];UNII-NXB79TB0N2
Molecular Formula:C15H21N3OS
Molecular Weight:291.41200
HS Code:2934100090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:417.1ºC at 760 mmHg
Density:1.158g/cm3
Index of Refraction:1.597
PSA:56.84000
Exact Mass:291.14100
LogP:2.71990
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like N-(4-Methoxy-benzyl)-N’,N’-dimethyl-N-thiazol-2-yl-aethylendiamin chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,UNII-NXB79TB0N2 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,N-(4-Methoxy-benzyl)-N’,N’-dimethyl-N-thiazol-2-yl-aethylendiamin Use and application,N-(4-methoxy-benzyl)-N’,N’-dimethyl-N-thiazol-2-yl-ethane-1,2-diamine technical grade,usp/ep/jp grade.
Related News: CHMP on Friday also announced that Roche pulled its Tecentriq application in triple-negative breast cancer after it noted that the EMA said the results from a late-stage trial do not favor the drug’s benefit-risk calculation in this indication. 4(15),5,10(14)-Germacratrien-1-ol manufacturers He joins us at a pivotal time as our Jinkō® platform goes from strength to strength as we expand our portfolio of partnerships. Grégoire’s strategic and operational expertise will be a vital part of our future success in accelerating and de-risking clinical trials. bis(prop-2-enyl) 1,2,3,4,7,7-hexachlorobicyclo[2.2.1]hept-2-ene-5,6-dicarboxylate suppliers Mene Pangalos, executive vice president, BioPharmaceuticals R&D, said: “The data being presented at EULAR add to the growing body of evidence for anifrolumab that demonstrate a compelling clinical profile with the potential to address significant unmet medical needs in this debilitating disease. 1-methylpyrazole-4-carbonyl chloride vendor & factory.
